AeroVironment director Michael Ruppert files initial beneficial ownership statement
AVAV•Initial Form 3 filing
- AeroVironment director Michael Ruppert filed an initial Form 3 statement on Aug. 14, 2026.*
Related News
CTT Pharmaceutical Holdings CEO Ryan Khouri acquires 1,800 common shares for $111.6
CTTH•
authID says Q2 2026 Form 10-Q filed with SEC, posted on investor site
AUID•
Howard Hughes Files For Mixed Shelf Size Not Disclosed
HHH•
Alphabet becomes Berkshire Hathaway's third-largest investment
BRK.A•
Actinium Pharmaceuticals Announces Actimab-A Intellectual Property And Manufacturing Advances And Provides NYSE American Listing Update
ATNM•